PHENCYCLIDINE-INDUCED INCREASES IN STRIATAL NEURON FIRING IN BEHAVING RATS - REVERSAL BY HALOPERIDOL AND CLOZAPINE

被引:19
|
作者
WHITE, IM [1 ]
FLORY, GS [1 ]
HOOPER, KC [1 ]
SPECIALE, J [1 ]
BANKS, DA [1 ]
REBEC, GV [1 ]
机构
[1] INDIANA UNIV, DEPT PSYCHOL, PROGRAM NEURAL SCI, BLOOMINGTON, IN 47405 USA
关键词
STRIATUM; PHENCYCLIDINE; DIZOCILPINE; NEUROLEPTICS;
D O I
10.1007/BF01276506
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amphetamine and related drugs of abuse facilitate dopamine transmission in the striatum. This action is believed to underlie the increase in firing of striatal motor-related neurons after amphetamine administration in behaving rats. The present study extended this electrophysiological investigation to phencyclidine (PCP), a nonamphetamine psychomotor stimulant that acts primarily as a noncompetitive antagonist of N-methyl-D-aspartate (NMDA) glutamate receptors. Like amphetamine, PCP (1.0, 2.5, or 5.0 mg/kg) increased the activity of striatal motor-related neurons concomitant with behavioral activation. These effects were blocked by subsequent administration of either 1.0 mg/kg haloperidol or 20.0 mg/kg clozapine, typical and atypical neuroleptics, respectively. Dizocilpine (MK-801), another noncompetitive NMDA antagonist, mimicked the effect of PCP. Collectively, these results indicate that amphetamine and NMDA antagonists exert comparable effects on striatal motor-related neurons, suggesting that the response of these cells to psychomotor stimulants is regulated by a dopaminergic-glutamatergic influence.
引用
收藏
页码:99 / 112
页数:14
相关论文
共 50 条
  • [31] M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice
    Wang, RY
    Liang, XF
    NEUROPSYCHOPHARMACOLOGY, 1998, 19 (01) : 74 - 85
  • [32] BIOCHEMICAL STUDIES OF STRIATAL CHOLINERGIC FUNCTION IN RATS RECEIVING CLOZAPINE, HALOPERIDOL AND CHLORPROMAZINE
    TRABUCCHI, M
    CHENEY, D
    RACAGNI, G
    COSTA, E
    JOURNAL DE PHARMACOLOGIE, 1974, 5 : 99 - 99
  • [33] M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice
    Wang R.Y.
    Liang X.
    Neuropsychopharmacology, 1998, 19 (1) : 74 - 85
  • [34] Early and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits
    Martinez, ZA
    Oostwegel, J
    Geyer, MA
    Ellison, GD
    Swerdlow, NR
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) : 517 - 527
  • [35] Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice
    Gleason, SD
    Shannon, HE
    PSYCHOPHARMACOLOGY, 1997, 129 (01) : 79 - 84
  • [36] Comparison of phencyclidine-induced spatial learning and memory deficits and reversal by sertindole and risperidone between Lister Hooded and Wistar rats
    Ihalainen, Jouni
    Savolainen, Katja
    Tanila, Heikki
    Forsberg, Markus M.
    BEHAVIOURAL BRAIN RESEARCH, 2016, 305 : 140 - 147
  • [37] “Early” and “Late” Effects of Sustained Haloperidol on Apomorphine- and Phencyclidine-induced Sensorimotor Gating Deficits
    Zoë A Martinez
    Jeff Oostwegel
    Mark A Geyer
    Gaylord D Ellison
    Neal R Swerdlow
    Neuropsychopharmacology, 2000, 23 : 517 - 527
  • [38] Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats
    Miyauchi, Masanori
    Neugebauer, Nichole M.
    Sato, Tatsuya
    Ardehali, Hossein
    Meltzer, Herbert Y.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (12) : 1588 - 1604
  • [39] Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions
    Shirayama, Y
    Mitsushio, H
    Takahashi, K
    Nishikawa, T
    SYNAPSE, 2000, 35 (04) : 292 - 299
  • [40] Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus
    Morita, T
    Sonoda, R
    Nakato, K
    Koshiya, K
    Wanibuchi, F
    Yamaguchi, T
    PSYCHOPHARMACOLOGY, 2000, 148 (03) : 281 - 288